Search research articles
Contact Us
Filters
Showing results (31-40 of 168) with videos related to
Page
of 17
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
June 12, 2014
The role of HIF1α in renal cell carcinoma tumorigenesis
Lorraine J Gudas, Leiping Fu, Denise R Minton, et al.
Biochemical Pharmacology
|
June 25, 2009
Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model
Sue Ellen Touma, Sven Perner, Mark A Rubin, et al.
The Journal of Urology
|
June 15, 2007
Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base
Kevin A David, Matthew I Milowsky, Jamie Ritchey, et al.
Biochimica Et Biophysica Acta
|
June 2, 2007
Bombesin attenuates pre-mRNA splicing of glucocorticoid receptor by regulating the expression of serine-arginine protein p30c (SRp30c) in prostate cancer cells
Jin Zhu, Jun Y Gong, Oscar B Goodman, et al.
Molecular Diagnosis & Therapy
|
May 10, 2014
Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential
Giuseppe Galletti, Luigi Portella, Scott T Tagawa, et al.
Anticancer Research
|
January 18, 2003
Detection of the p110 beta subunit of phosphatidylinositol 3-kinase complexed with neutral endopeptidase
Ruoqian Shen, Matthew I Milowsky, Naoko Ozaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
Synergistic activation of the androgen receptor by bombesin and low-dose androgen
Jie Dai, Ruoqian Shen, Makoto Sumitomo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2005
Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer
Neil H Bander, Matthew I Milowsky, David M Nanus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Radioimmunotherapy of prostate cancer using 90Y- and 177Lu-labeled J591 monoclonal antibodies: effect of multiple treatments on myelotoxicity
Shankar Vallabhajosula, Stanley J Goldsmith, Lale Kostakoglu, et al.
International Journal of Oncology
|
March 9, 2005
Retinoid receptor mRNA expression profiles in human bladder cancer specimens
Stephen Boorjian, Douglas S Scherr, Nigel P Mongan, et al.
Page
of 17
Search research articles
Search
Showing results (31-40 of 168) with videos related to
Sort By:
Page
of 17
Journal of Molecular Medicine (Berlin, Germany)
|
June 12, 2014
The role of HIF1α in renal cell carcinoma tumorigenesis
Lorraine J Gudas, Leiping Fu, Denise R Minton, et al.
Biochemical Pharmacology
|
June 25, 2009
Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model
Sue Ellen Touma, Sven Perner, Mark A Rubin, et al.
The Journal of Urology
|
June 15, 2007
Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base
Kevin A David, Matthew I Milowsky, Jamie Ritchey, et al.
Biochimica Et Biophysica Acta
|
June 2, 2007
Bombesin attenuates pre-mRNA splicing of glucocorticoid receptor by regulating the expression of serine-arginine protein p30c (SRp30c) in prostate cancer cells
Jin Zhu, Jun Y Gong, Oscar B Goodman, et al.
Molecular Diagnosis & Therapy
|
May 10, 2014
Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential
Giuseppe Galletti, Luigi Portella, Scott T Tagawa, et al.
Anticancer Research
|
January 18, 2003
Detection of the p110 beta subunit of phosphatidylinositol 3-kinase complexed with neutral endopeptidase
Ruoqian Shen, Matthew I Milowsky, Naoko Ozaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
Synergistic activation of the androgen receptor by bombesin and low-dose androgen
Jie Dai, Ruoqian Shen, Makoto Sumitomo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2005
Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer
Neil H Bander, Matthew I Milowsky, David M Nanus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Radioimmunotherapy of prostate cancer using 90Y- and 177Lu-labeled J591 monoclonal antibodies: effect of multiple treatments on myelotoxicity
Shankar Vallabhajosula, Stanley J Goldsmith, Lale Kostakoglu, et al.
International Journal of Oncology
|
March 9, 2005
Retinoid receptor mRNA expression profiles in human bladder cancer specimens
Stephen Boorjian, Douglas S Scherr, Nigel P Mongan, et al.
Page
of 17